Novo Nordisk A S NVO
NYSE NVO
$38.89 -0.56 (-1.42%)
At close: Nov 19, 2026 · 4:00 PM EST

Novo Nordisk A S (NVO) EBIT (2012 - 2016)

Updated

Novo Nordisk A S (NVO) posted EBIT of $1.62 billion for the quarter ended Dec 31, 2016.

Analysis

Novo Nordisk A S (NVO) EBIT (2012 - 2016) Analysis & Trends

For the trailing twelve months through Dec 31, 2016, EBIT at Novo Nordisk A S was $84.41 billion; for the year ended Dec 31, 2014, it was $34.49 billion, up 9.5% from the prior year.

  • Annual EBIT has increased for five consecutive years, with a five-year compound annual growth rate of 18.2% (years ended Dec 2009 to Dec 2014).
  • In prior years, Novo Nordisk A S's EBIT was $31.49 billion in the year ended Dec 31, 2013 (+6.9%), $29.47 billion in the year ended Dec 31, 2012 (+31.7%), $22.37 billion in the year ended Dec 31, 2011 (+18.4%) and $18.89 billion in the year ended Dec 31, 2010 (+26.5%).
  • The figure for the quarter ended Dec 31, 2016 stands as the highest quarterly EBIT since the quarter ended Dec 31, 2014.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 1.62 Bn
Dec 31, 2014 60.48 Bn
Dec 31, 2012 1.32 Bn
API Access

Novo Nordisk A S EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=NVO&period=max&api_key=YOUR_API_KEY